MBIO
MBIO
NASDAQ · Biotechnology

Mustang Bio Inc

$0.79
+0.08 (+10.53%)
As of Feb 8, 2:31 PM ET ·
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Buy 6 86%
Hold 1 14%
Sell 0 0%
Price Target
Analyst Price Target +1,212.2% upside
Low Target $6.34
Average Target $10.33
High Target $12.82
Current Price $0.79
Current
$0.79
Target
$10.33
$6.34 $10.33 avg $12.82
Scenario Analysis
Bear Case
$6.34
705.4%
Low target
Base Case
$10.33
+1,212.2%
Avg target
Bull Case
$12.82
+1,528.6%
High target
Risk/Reward
2.2x
Favorable
Price in Context
52-Week High
$10.93
-92.8% from high
52-Week Low
$6.81
+-88.4% from low
Target vs 52W High
$10.33
-5.5% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Buy 37 68% $257.58 +15.3%
AMGN
Amgen Inc
Hold 41 54% $190.87 -50.3%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +137.8%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 77% $438.34 -8.3%
REGN
Regeneron Pharmaceuticals
Strong Buy 36 75% $76.80 -90.2%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 75% $102.31 -68.8%
INSM
Insmed Inc
Strong Buy 27 93% $143.40 -4.3%
BIIB
Biogen Inc
Hold 42 48% $91.45 -54.5%